Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 25, 2019
Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway
Lauren Tomlinson, Zhen Qi Lu, Robert A Bentley, et al.
Experimental Cell Research
|
March 17, 2007
Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer
Emma Rennel, Sofie Mellberg, Anna Dimberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 13, 2009
Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis
Sofie Mellberg, Anna Dimberg, Fuad Bahram, et al.
Angiogenesis
|
March 9, 2017
RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells
Ahmad F Alghanem, Emma L Wilkinson, Maxine S Emmett, et al.
Molecular Pharmaceutics
|
June 27, 2018
Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process
David Dickens, Steffen Rädisch, George N Chiduza, et al.
Mabs
|
December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist
Thilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.
Cancer Research Communications
|
December 5, 2022
Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition
Jingwei Zhang, Adam J Pearson, Nitin Sabherwal, et al.
Free Radical Biology & Medicine
|
December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
Annals of Surgical Oncology
|
November 22, 2020
A Three-Dimensional Bioabsorbable Tissue Marker for Volume Replacement and Radiation Planning: A Multicenter Study of Surgical and Patient-Reported Outcomes for 818 Patients with Breast Cancer
Cary S Kaufman, Michael J Cross, Julie L Barone, et al.
Stem Cells Translational Medicine
|
February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies
James A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 25, 2019
Attenuation of doxorubicin-induced cardiotoxicity in a human in vitro cardiac model by the induction of the NRF-2 pathway
Lauren Tomlinson, Zhen Qi Lu, Robert A Bentley, et al.
Experimental Cell Research
|
March 17, 2007
Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer
Emma Rennel, Sofie Mellberg, Anna Dimberg, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 13, 2009
Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis
Sofie Mellberg, Anna Dimberg, Fuad Bahram, et al.
Angiogenesis
|
March 9, 2017
RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells
Ahmad F Alghanem, Emma L Wilkinson, Maxine S Emmett, et al.
Molecular Pharmaceutics
|
June 27, 2018
Cellular Uptake of the Atypical Antipsychotic Clozapine Is a Carrier-Mediated Process
David Dickens, Steffen Rädisch, George N Chiduza, et al.
Mabs
|
December 18, 2014
Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist
Thilipan Thaventhiran, Naif Alhumeed, Han X A Yeang, et al.
Cancer Research Communications
|
December 5, 2022
Inhibiting ERK5 overcomes breast cancer resistance to anti-HER2 therapy by targeting the G1/S cell cycle transition
Jingwei Zhang, Adam J Pearson, Nitin Sabherwal, et al.
Free Radical Biology & Medicine
|
December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
Annals of Surgical Oncology
|
November 22, 2020
A Three-Dimensional Bioabsorbable Tissue Marker for Volume Replacement and Radiation Planning: A Multicenter Study of Surgical and Patient-Reported Outcomes for 818 Patients with Breast Cancer
Cary S Kaufman, Michael J Cross, Julie L Barone, et al.
Stem Cells Translational Medicine
|
February 28, 2015
Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies
James A Heslop, Thomas G Hammond, Ilaria Santeramo, et al.
Page
of 4